POST Online Media Lite Edition


Philips and Masimo sign multi-year partnership agreement

Staff Writer |
Royal Philips and Masimo Corporation announced a wide-ranging, multi-year business partnership involving both companies’ innovations in patient monitoring and therapy solutions.

The partnership includes joint marketing and sales programs in North America and certain markets in Asia and Europe for Masimo’s non-invasive sensor technologies, such as its rainbow and SET platforms, in conjunction with Philips’ patient monitoring and select therapy solutions.

In addition, Philips will in the future integrate Masimo SedLine brain function monitoring, O3 regional oximetry, and Nomoline capnography technologies in certain Philips IntelliVue monitors.

Sensor and signal processing technologies are an essential component of patient monitoring solutions, and Masimo is a prolific innovator in this field.

Examples of Masimo’s non-invasive sensor and signal processing technology innovations include Masimo SET pulse oximetry, Masimo rainbow Pulse CO-Oximetry and Masimo total hemoglobin (SpHb®) monitoring technology.

What to read next

Philips and Nintendo resolve patent disputes
Philips to buy Spectranetics for 1.9 billion euros
Philips to implement a new management structure in Healthcare